Histidine 265 is important for covalent catalysis by vaccinia topoisomerase and is conserved in all eukaryotic type I enzymes

被引:53
作者
Petersen, BO
Shuman, S
机构
[1] Molecular Biology Program, Sloan-Kettering Institute, New York
关键词
D O I
10.1074/jbc.272.7.3891
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vaccinia topoisomerase catalyzes DNA cleavage and rejoining via transesterification to pentapyrimidine recognition site 5'-(CPT)CCTT down arrow in duplex DNA. The proposed reaction mechanism involves general-base catalysis of the attack by active site nucleophile Tyr-274 on the scissile phosphodiester and general-acid catalysis of the expulsion of the 5'-deoxyribose oxygen on the leaving DNA strand, The pK(a) values suggest histidine and cysteine side chains as candidates for the roles of proton acceptor and donor, respectively, To test this, we replaced each of the eight histidines and two cysteines of the vaccinia topoisomerase with alanine, Single mutants C100A and C211A and a double mutant C100A-C211A were fully active in DNA relaxation, indicating that a cysteine is not the general acid, Only one histidine mutation, H265A, affected enzyme activity, The rates of DNA relaxation, single-turnover strand cleavage, and single-turnover religation by H265A were 2 orders of magnitude lower than the wild-type rates, Yet the H265A mutation did not alter the dependence of the cleavage rate on pH, indicating that His-265 is not the general base, Replacing His-265 with glutamine or asparagine slowed DNA relaxation and single-turnover cleavage to about one-third of the wild-type rate, All three mutations, H265A, H265N, and H265Q, skewed the cleavage-religation equilibrium in favor of the covalently bound state, His-265 is strictly conserved in every member of the eukaryotic type I topoisomerase family.
引用
收藏
页码:3891 / 3896
页数:6
相关论文
共 30 条
  • [1] Caron P R, 1994, Adv Pharmacol, V29B, P271
  • [2] ENG WK, 1989, J BIOL CHEM, V264, P13373
  • [3] THE TOPOISOMERASE-I GENE FROM USTILAGO-MAYDIS - SEQUENCE, DISRUPTION AND MUTANT PHENOTYPE
    GERHOLD, D
    THIYAGARAJAN, M
    KMIEC, EB
    [J]. NUCLEIC ACIDS RESEARCH, 1994, 22 (18) : 3773 - 3778
  • [4] EUKARYOTIC DNA TOPOISOMERASES-I
    GUPTA, M
    FUJIMORI, A
    POMMIER, Y
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1995, 1262 (01): : 1 - 14
  • [5] GUPTA M, 1994, J BIOL CHEM, V269, P573
  • [6] SITE-DIRECTED MUTAGENESIS BY OVERLAP EXTENSION USING THE POLYMERASE CHAIN-REACTION
    HO, SN
    HUNT, HD
    HORTON, RM
    PULLEN, JK
    PEASE, LR
    [J]. GENE, 1989, 77 (01) : 51 - 59
  • [7] Purification and characterization of human topoisomerase I mutants
    Jensen, AD
    Svejstrup, JQ
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 236 (02): : 389 - 394
  • [8] KLEMPERER N, 1993, J BIOL CHEM, V268, P15887
  • [9] IDENTIFICATION AND CHARACTERIZATION OF THE ORF VIRUS TYPE-I TOPOISOMERASE
    KLEMPERER, N
    LYTTLE, DJ
    TAUZIN, D
    TRAKTMAN, P
    ROBINSON, AJ
    [J]. VIROLOGY, 1995, 206 (01) : 203 - 215
  • [10] LEVIN NA, 1993, GENETICS, V133, P799